Real-time enrollment status for this hereditary angioedema clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT06842823 |
| Recruiting Status | Recruiting |
| Condition | Hereditary Angioedema |
| Phase | Clinical Trial |
| Target Enrollment | 145 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Astria Therapeutics, Inc. |
| Last Updated on CT.gov | February 11, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT06842823 is currently recruiting participants. This clinical trial study for hereditary angioedema is actively seeking new participants at 14 locations across the United States. The study is sponsored by Astria Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06842823 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06842823 was last updated 2 weeks ago (February 11, 2026). HelloStudys verifies this status automatically.